Biocept News, Biocept Quote, BIOC Quote

Biocept (NQ:BIOC) Delayed: 0.43 --0 (-0%)

Prev. Close

$0.43

Open

$0.43

52 Wk High

$2.03

52 Wk Low

$0.49

Day High

$0.43

Day Low

$0.43

P/E

N/A

EPS

$-4.91

Volume

354

Friends, Peers and Foes (?): PSTV, FRCB, APPS, WBA, NVDA (more...)

Nov 20, 2023 08:48 AM Form 25-NSE BIOCEPT INC Filed by: Nasdaq Stock Market LLC
Oct 20, 2023 06:06 AM Form 8-K BIOCEPT INC For: Oct 16
Oct 16, 2023 08:54 AM Form 8-K BIOCEPT INC For: Oct 13
Sep 21, 2023 08:00 AM Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases
Sep 8, 2023 08:01 AM Biocept (BIOC) Signs CNSide Licensing Agreement with Plus Therapeutics (PSTV)
Sep 8, 2023 08:00 AM Biocept Signs CNSide™ Licensing Agreement with Plus Therapeutics
Sep 5, 2023 08:00 AM Biocept to Participate in the H.C. Wainwright Global Investment Conference
Aug 25, 2023 08:00 AM Biocept to Hold Business Update Conference Call on August 30, 2023
Aug 22, 2023 04:11 PM Form 8-K BIOCEPT INC For: Aug 14
Aug 14, 2023 04:33 PM Form 10-Q BIOCEPT INC For: Jun 30

Entities mentioned with BIOC